INKT icon

MiNK Therapeutics
INKT

Overview Fund Trends Analyst Outlook Journalist POV

11 hedge funds and large institutions have $504K invested in MiNK Therapeutics in 2022 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 7 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 13

Holders
11
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$804
2
+$568

Top Sellers

1
-$745K
2
-$58K
3
-$38K
4
Vanguard Group
Vanguard Group
Pennsylvania
-$23K
5
New York State Common Retirement Fund
New York State Common Retirement Fund
New York
-$18K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$408K
2
$50K
3
$32K
4
$10K
5
$2K
6
$1K
7
$1K
8
–
9
–
10
–
11
–
12
–
13
–
14
–
15
–
16
–
17
–